The endocrine effects of spironolactone used as an antiandrogen
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Eight castrate, estrogen-replaced women were given 200 mg spironolactone daily for 4 weeks. The response of plasma dehydroepiandrosterone sulfate (DHEAS), testosterone (T), and androstenedione (delta 4A), all indicators of adrenal C19-steroid production, varied greatly among individuals. Sixteen women with idiopathic hirsutism were given night-time dexamethasone (DEX) and then superimposed spironolactone for 4 weeks, followed by DEX without spironolactone for an additional 4 weeks. As expected, DHEAS, T, and delta 4A declined on DEX treatment. On addition of spironolactone, there was little further change in DHEAS, while plasma T declined in 7 of 16 women, including all those whose T level had remained elevated despite DEX treatment; most values rebounded when spironolactone was discontinued. The authors conclude from intact DEX-suppressed women that ovarian T, especially when increased, is frequently lowered by spironolactone. Thus, both adrenal and ovarian androgen production (as measured by prevailing plasma levels) may be diminished by this agent. These highly variable effects on androgen production are unlikely to account for the consistent antiandrogenic effects reported clinically.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spironolactone has several antiandrogen effects such as androgen receptor blockade, aromatase stimulation, and direct effect of partial blockade of androgen synthesis, not only in the gonads but also in the adrenals through a direct effect on ovarian and adrenal androgen synthesis [26,73].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [73]
Citations
Cites
Antiandrogenic Effect of Spirolactones: Mechanism of Action
CORVOL, P., MICHAUD, A., MENARD, J., FREIFELD, M., & MAHOUDEAU, J. (1975) · Endocrinology · doi:10.1210/endo-97-1-52 · Cited by 259
Treatment of Hirsutism With Spironolactone
Cumming, D. C. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320340049034 · Cited by 232
Pathophysiology of Spironolactone-Induced Gynecomastia
ROSE, L. I., UNDERWOOD, R. H., NEWMARK, S. R., KISCH, E. S., & WILLIAMS, G. H. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-398 · Cited by 193
Oral spironolactone improves acne vulgaris and reduces sebum excretion
GOODFELLOW, A., ALAGHBAND-ZADEH, J., CARTER, G., CREAM, J. J., HOLLAND, S., SCULLY, J., & WISE, P. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04045.x · Cited by 172
Spironolactone and Endocrine Dysfunction
LORIAUX, D. L., MENARD, R., TAYLOR, A., PITA, J. C., & SANTEN, R. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-5-630 · Cited by 170
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
Løbo, R. A., Shoupe, D., Serafini, P. C., Brinton, D., & Horton, R. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48373-1 · Cited by 154
Givens, J. R., Andersen, R. N., Ragland, J. B., Wiser, W. L., & Umstot, E. S. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-6-988 · Cited by 130
A Novel Use of Spironolactone: Treatment of Hirsutism
SHAPIRO, G., & EVRON, S. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-429 · Cited by 127
Effect of Spironolactone on Sex Hormones in Man
STRIPP, B., TAYLOR, A. A., BARTTER, F. C., GILLETTE, J. R., LORIAUX, D. L., EASLEY, R., & MENARD, R. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-4-777 · Cited by 102
GOLDZIEHER, J. W., DOZIER, T. S., SMITH, K. D., & STEINBERGER, E. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-4-824 · Cited by 102
Self-citation
Research works printed but not linked: 1
- Ebner, 1963, Experiments with aldactone and metopirone in acne vulgaris and endogenous eczema, Wien Med Wochenschr, 113, 253
Cited by
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“Spironolactone has several antiandrogen effects such as androgen receptor blockade, aromatase stimulation, and direct effect of partial blockade of androgen synthesis, not only in the gonads but also in the adrenals through a direct effect on ovarian and adrenal androgen synthesis [26,73].”
BackgroundAzziz, R., Carmina, E., & Sawaya, M. E. (2000) · Endocrine Reviews · doi:10.1210/er.21.4.347 · Cited by 348
A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs
Girardi, E., César‐Razquin, A., Lindinger, S., Παπακώστας, Κ., Konecka, J., Hemmerich, J., Kickinger, S., Kartnig, F., Gürtl, B., Klavins, K., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0483-3 · Cited by 155
Spironolactone in dermatologic therapy
Shaw, J. C. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70034-y · Cited by 108
Treatment of polycystic ovary syndrome with spironolactone plus licorice
Armanini, D., Castello, R., Scaroni, C. M., Bonanni, G., Faccini, G., Pellati, D., Bertoldo, A., Fiore, C., & Moghetti, P. (2006) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.013 · Cited by 75
Metadata
- Authors
- Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K.
- Affiliations
- Baylor College of Medicine (US)
- ORCID
- Elkind-Hirsch, Karen
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1987-08
- Volume
- 48
- Issue
- 2
- Pages
- 223-228
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W18535981
- Cited by
- 38
- References
- 24
- Citations by year
- 2024: 1 · 2022: 2 · 2020: 3 · 2018: 4 · 2017: 1 · 2015: 1 · 2013: 3
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 12718 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- spironolactone, androgen receptor antagonists, endocrine effects, adrenal androgen production, ovarian androgen production, testosterone, dehydroepiandrosterone sulfate, androstenedione, dexamethasone suppression, idiopathic hirsutism, estrogen replacement therapy
- MeSH terms
- Adult, Androstenedione, Dehydroepiandrosterone, Dexamethasone, Female, Hirsutism, Humans, Middle Aged, Ovariectomy, Spironolactone, Testosterone, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The endocrine effects of spironolactone used as an antiandrogen. https://app.cochat.ai/papers/10.1016/s0015-0282(16)59346-7
- The paper
- Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K. (1987). The endocrine effects of spironolactone used as an antiandrogen. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(16)59346-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.